Dog survives 6 months with metastatic hemangiosarcoma

The Johns Hopkins Center for Image-Guided Animal Therapy began testing an FDA-approved drug normally used for human breast cancer in 2017. The hemangiosarcoma clinical trial is now closed to new participants and the first results have been released.

Thirteen dogs were screened for the trial and only three were selected to participate because their cancer had spread throughout their body and they were able to “absorb” the form of chemotherapy offered. Of those three, only a terrier mix named Josie survived the clinical trial, living six months with metastatic hemangiosarcoma.

Read more here: Dog becomes first to survive clinical trial for one of the most deadly pet cancers

Share your thoughts

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s